In this recorded webinar, the National Foundation for Infectious Diseases (NFID), the American Pharmacists Association, and the Hepatitis B Foundation host a discussion during Hepatitis Awareness Month on the prevention of hepatitis B infection in US adults. Topics addressed include current US recommendations for hepatitis B vaccination and screening in adults, along with strategies for effective communication of current recommendations.
NFID Medical Director Robert (Bob) H. Hopkins, Jr., MD, moderates the discussion with NFID Director Jean-Venable (Kelly) R. Goode, PharmD, Professor and Director, Virginia Commonwealth University; Lindsey Sizemore, MPH, CPH, Clinical Interventions Team Lead, Division of Viral Hepatitis, Centers for Disease Control and Prevention; and Su Wang, MD, MPH, Senior Advisor for Global Health, Hepatitis B Foundation.
At the conclusion of this activity, participants will be able to:
- Describe the burden of hepatitis B in the US
- Discuss current hepatitis B vaccination and screening recommendations for US adults
- Discuss strategies to increase hepatitis B vaccination rates among US adults
There is no fee to participate in this activity, but pre-registration is required.
This activity is being jointly provided by the National Foundation for Infectious Diseases and the American Pharmacists Association.
The National Foundation for Infectious Diseases (NFID) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
NFID designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE). Preventing Hepatitis B Infection in US Adults is approved for a total of 1.0 contact hour of continuing pharmacy education (CPE) credit (0.1 CEUs). The ACPE Universal Activity Number for this activity is 0202-9999-24-037-L.
This nursing continuing professional development activity is approved by the Virginia Nurses Association, an accredited approver by the American Nurses Credentialing Center Commission on Accreditation.
This webinar is supported by an unrestricted educational grant from Dynavax. NFID policies restrict funders from controlling program content.
Additional Resources:
Clinical Testing and Diagnosis of Hepatitis B (Centers for Disease Control and Prevention [CDC])
Hepatitis B Vaccine Administration (CDC)
Medicare Part D Vaccines Fact Sheet (Centers for Medicare & Medicaid Services)
Screening and Testing for Hepatitis B Infection (CDC)